SPNE News and Press, SeaSpine Holdings Corporation From 02/22/21

CARLSBAD, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release fourth quarter financial results after the close of...

CARLSBAD, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its 3D-printed WaveForm TA (TLIF Articu...

SeaSpine Holdings (SPNE) announces the limited commercial launch of its Regatta Lateral Plate System, which would allow  for multiple plating options, including one, two, and four-hole plates.The launch marks the first standalone lateral plate for SeaSpine. The plate system is designed t...

CARLSBAD, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its Regatta Lateral Plate System. ...

SeaSpine Holdings Corporation (SPNE) expects Q4 revenue in the range of $46.2M-$46.6M (+6 to +7% Y/Y) vs. consensus of $47.27M. U.S. Spinal Implants revenue is expected to reflect growth within the 7% to 8% range and U.S. Orthobiologics revenue is expected to reflect growth within the 6% to 7...

CARLSBAD, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the fourth quarter and full-year 2020,...

SeaSpine has differentiated products in orthobiologics and spinal implant as well as some new products in the pipeline which will expand its TAM. SeaSpine's historical revenue growth has not been impressive, and the company has been operating at a loss for the last five years. I w...

CARLSBAD, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has received 510(k) clearance from the U.S. Food and Drug Admini...

CARLSBAD, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its Meridian ALIF (anterior lumbar inte...

CARLSBAD, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch and subsequent first case of its Admi...